NCT03550651

Brief Summary

Periodontal disease is a multifactorial disease caused by mainly bacterial, genetic, immunological, and environmental factors. Chronic periodontitis, one of the widely prevalent forms of periodontal disease, is characterized by loss of attachment apparatus of the tooth; it can lead to tooth loss. Many non surgical and surgical approaches have been adapted time and again to prevent, intercept, and to treat the various forms of chronic periodontitis. But, these treatment modalities are not approachable by all individuals, because of the various factors such as: low socioeconomic status, illiteracy, high cost of the treatment, no availability of easy and uncomplicated treatment nearby etc. Considering these factors, there are still a need of preventive, practical, and affordable treatment options specially for the population of underdeveloped and developing countries.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2017

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2017

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 8, 2018

Completed
Last Updated

June 8, 2018

Status Verified

May 1, 2018

Enrollment Period

10 months

First QC Date

March 10, 2018

Last Update Submit

June 7, 2018

Conditions

Keywords

PlaquePlaque regrowthLicorice extractMouthrinseChlorhexidine mouthrinseHypertonic salt solutionEssential oils

Outcome Measures

Primary Outcomes (1)

  • Modified Plaque Index

    Modified Plaque Index (Turesky, Gilmore, Glickman modification of Quigely Hein Index, 1970) after disclosing the teeth with two tone solution the PI was recorded. Facial and lingual aspects were scored with PI. Scoring was as follows: 0 - No plaque/debris 1 - Separate flecks of plaque at the cervical margin of the tooth. 2 - A thin continuous band of plaque (up to 1mm) at the cervical margin of the tooth. 3 - A band of plaque wider than 1 mm but covering less than one third of the crown of the tooth 4 - plaque covering at least one third but less than two thirds of the crown of the tooth. 5 - Plaque covering two third or more of the crown of the tooth. Modified Plaque Index = Total score / no. of surfaces examined.

    After 4 days

Other Outcomes (2)

  • Minimum inhibitory concentration

    72 hours

  • Minimum bactericidal concentration

    72 hours

Study Arms (5)

Licorice extract mouthrinse

EXPERIMENTAL

10ml twice a day for 4 Days.

Other: Licorice

Hypertonic salt solution

EXPERIMENTAL

10ml twice a day for 4 Days.

Other: Hypertonic salt solution

Essential oil mouthrinse

ACTIVE COMPARATOR

10ml twice a day for 4 Days.

Other: Essential oil

Chlorhexidine Gluconate mouthrinse

ACTIVE COMPARATOR

10ml twice a day for 4 Days.

Other: Chlorhexidine Gluconate

Distilled water

PLACEBO COMPARATOR

10ml twice a day for 4 Days.

Other: Distilled water

Interventions

Licorice, since years is known for its anti-inflammatory, antimicrobial, antiviral, antiprotozoal, antioxidative, hepatoprotective, cardioprotective, immunomodulatory and antitumour activity. Licorice can be beneficial for oral health. Glycyrrhizin, the sweet component of licorice root has antiplaque property. Pterocarpenes isolated from G. uralensis root extract exerts an antibacterial activity against Streptococcus mutans.

Also known as: Glycyrrhiza
Licorice extract mouthrinse

The antiseptic and bactericidal qualities of salt help in removing plaque which is a cause of gingivitis and caries. Warming water with a pinch of table salt can reduce or even be an alternative to anti-inflammatory drugs intra-orally. Its high osmolality reduces inflammation and can be microbicidal. Moreover, efficacy of luke warm hypertonic salt solution has shown antimicrobial, anti-inflammatory and immunomodulatory properties.

Hypertonic salt solution

Essential oils have a wide application in folk medicine, food flavoring and preservation as well as in fragrance industries. The antimicrobial properties of essential oils have been known for many centuries. In recent years, a large number of essential oils and their constituents have been investigated for their antimicrobial properties against some bacteria and fungi. Essential oils have the potential to be used as therapeutic agents for chronic gingivitis and periodontitis conditions that have both bacterial and inflammatory components.

Essential oil mouthrinse

Chlorhexidine is a symmetrical bisbiguanide synthetic antiseptic. It is available in three forms, digluconate, acetate and hydrochloride salts. Which have broad spectrum antimicrobial activity; it is effective against both Gram-positive and Gram-negative bacteria including aerobes and anaerobes, yeasts, fungi and lipid enveloped viruses. Chlorhexidine is considered to be the most effective plaque inhibitor against which other antiplaque agents are measured.

Also known as: Chlorhexidine
Chlorhexidine Gluconate mouthrinse

Distilled water is commonly placebo in various research projects and it is also useful in as placebo treatment.

Distilled water

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • General/Medical
  • Any race/ethnic group
  • Aged - 18-30 years
  • Male or female

You may not qualify if:

  • Non-smoker, Non-alcoholic
  • Who was ready to comply with study procedures
  • Who was available for the duration of the study
  • Who were ready to provide signed informed consent Oral/Periodontal
  • <!-- -->
  • Dentate with at least 14 natural teeth, excluding third molars, that can be evaluated periodontally.
  • Patients with Healthy periodontium and/or Mild Gingivitis.
  • No acute oral diseases (mucosal lesions), oral infections, need for immediate dental/periodontal care (e.g., NUG).
  • General/Medical A) Any known systemic disease which has effects on periodontium such as diabetes, cardiovascular, cancer etc.
  • B) Volunteers on anti-inflammatory, antibiotics, steroids, cytotoxic, and perioceutics, since 03 months.
  • C) Volunteers who are known allergic to any substance. D) Pregnant and lactating mothers. E) Volunteers who had dental caries. F) Tobacco users (smoke and smokeless) and Alcoholics. G) Volunteers wearing any form of intraoral prosthesis or appliance. Oral/Periodontal
  • \<14 teeth that can be periodontally evaluated (excluding 3rd molars)
  • Dental volunteers with compromised periodontal status/ any sign of moderate or severe gingivitis and periodontitis.
  • Acute oral infections.
  • Oral wounds, including recent extractions.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Periodontal DiseasesPlaque, Amyloid

Interventions

Glycyrrhiza glabra extractOils, Volatilechlorhexidine gluconateChlorhexidine

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OilsLipidsBiguanidesGuanidinesAmidinesOrganic Chemicals

Study Officials

  • Dr Subhash Garg

    Govt. College of Dentistry Indore, M.P. India,Indore, M.P, India, 452001

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: 5x5 latin cross over study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Graduate Student

Study Record Dates

First Submitted

March 10, 2018

First Posted

June 8, 2018

Study Start

August 1, 2016

Primary Completion

May 15, 2017

Study Completion

June 10, 2017

Last Updated

June 8, 2018

Record last verified: 2018-05